D-0307-2021 Class III Terminated
FDA drug recall D-0307-2021 was initiated by Edge Pharma, LLC on Dec 22, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is terminated (terminated Jun 10, 2021). Affected quantity: 60 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 24, 2021
- Initiation Date
- Dec 22, 2020
- Termination Date
- Jun 10, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 60 syringes
Product description
Epinephrine/Lidocaine HCl, Sterile Ophthalmic Solution for Injection, 0.8 mL per syringe, Single Use Syringe, 0.025%/0.75%, Rx only, Edge Pharma LLC 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0863-01
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution pattern
PA only
Code information
Lot #: 10-2020-13@8, exp. date 12/03/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0307-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026